Skip to main content

Biohacking

More in Biohacking

ExplainerRegulatory Policy

How the FDA Uses AI to Identify Drug Responders in Landmark Regulatory Shift

Regulatory Innovators 40%Clinical Data Scientists 35%Traditional Diagnosticians 25%

3 sources · 21d ago

ExplainerImmune Aging

Study Finds Adult Thymus is Not 'Defunct,' Plays Profound Role in Longevity and Cancer Defense

Immunologists & Oncologists 40%Cardiothoracic Surgeons 35%Longevity Researchers 25%

8 sources · 32d ago

Epigenetic ReprogrammingClinical Trial Explainer

First Human Dosed With Cellular Reprogramming Injection in Landmark 'Reverse-Aging' Trial

Longevity Advocates 40%Cautious Biologists 35%Biotech Investors 25%

6 sources · 33d ago

Genetic MedicineBreakthrough Explainer

First In-Vivo CRISPR Therapy Achieves Phase 3 Success, Curing Hereditary Angioedema in 62% of Patients

Clinical Researchers 35%Biotech Industry & Investors 35%Patient Advocacy & Medical News 30%

8 sources · 35d ago

ExplainerMedical Breakthrough

Genetically Modified Pig Organs Successfully Transplanted into Humans, Ending Decades-Long Xenotransplantation Barrier

Transplant Surgeons & Researchers 45%Waitlist Patients & Advocates 35%Bioethicists & Animal Welfare Advocates 20%

3 sources · 40d ago

Genetic MedicineBreakthrough Explainer

World's First Bespoke CRISPR Therapy Cures Infant With Rare Genetic Disease, Paving Way for 'N-of-1' Medicine

Clinical Innovators 40%Biotech & Manufacturing 35%Patient Advocates 25%

2 sources · 51d ago

ExplainerLongevity Regulation

FDA and CMS Open Historic Dialogue on Regulating Aging as a Treatable Condition

Longevity Biotech Founders 40%Regulatory Pragmatists 35%Health Equity Advocates 25%

3 sources · 55d ago

Peptide RegulationExplainer

The Evidence Pack: How an Imminent FDA Hearing Will Decide the Fate of BPC-157 and TB-500

Biohackers & Longevity Advocates 40%Regulatory & Safety Officials 35%Compounding Pharmacists 25%

2 sources · 57d ago

Epigenetic ReprogrammingClinical Trial

First Human Trial of Cellular Reprogramming Drug Begins, Targeting Age Reversal in the Optic Nerve

Longevity Biotech Advocates 45%Clinical Ophthalmologists 35%Safety & Regulatory Monitors 20%

3 sources · 57d ago

Precision OncologyExplainer

Landmark Trial: Eli Lilly Drug Slashes Early-Stage Lung Cancer Recurrence Risk by 83%

Clinical Oncologists 45%Patient Advocates 35%Pharmaceutical Industry 20%

3 sources · 61d ago

Biohacking LimitsMedical Explainer

Biohacker Bryan Johnson Diagnosed With 'Incurable' Autoimmune Gastritis

Medical Realists 45%Longevity Optimists 30%Autoimmune Patient Advocates 25%

3 sources · 52d ago

ExplainerMetabolic Health

Why Continuous Glucose Monitors Became the Defining Wellness Tech of 2026

Metabolic Optimization Advocates 40%Traditional Medical Skeptics 30%Public Health Officials 30%

4 sources · 78d ago

ExplainerLongevity Science

Experimental 'Exercise Mimetic' Drug Shows Promise in Early Human Trials

Longevity Researchers 45%Metabolic Specialists 35%Clinical Skeptics 20%

3 sources · 80d ago

CRISPR MilestoneExplainer

Single-Dose In-Vivo CRISPR Therapy Achieves World's First Phase 3 Win, Validating Gene Editing Platform

Gene Editing Researchers 38%HAE Patient Advocates 38%Biotech Analysts 25%

3 sources · 56d ago

ExplainerPeptide Therapy

How Peptides Moved From Underground Biohacking to Mainstream Medicine

Longevity & Telehealth Advocates 40%Regulatory & Safety Watchdogs 35%Compounding Pharmacy Industry 25%

4 sources · 87d ago

Genetic MedicineExplainer

A New 'Base Editing' Technique Corrects Genetic Diseases in Human Embryos Without CRISPR's Damage

Genetic Researchers & Innovators 45%Bioethicists & Religious Objectors 30%Scientific Watchdogs & Safety Advocates 25%

4 sources · 87d ago

ExplainerMetabolic Health

Why Millions of Non-Diabetics Are Wearing Continuous Glucose Monitors

Metabolic Optimizers 44%Clinical Traditionalists 33%Diabetes Advocates 22%

3 sources · 91d ago